Arkolith/Insider Trading/KPRX/Form 4

Strem Brian M.

President and CEO, DirectorKIORA PHARMACEUTICALS INC (KPRX) · full profile →Form 4 · filed Jul 3, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2024Grant(A)16K—$030K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2024Grant(A)31K—$031K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001372514-24-000097) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML